Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.
Flow cytometric DNA-ploidy analysis was used to investigate intratumor DNA stemline heterogeneity in primary breast carcinomas and lymph node metastases (LNM). The study was done in tumor specimens from 44 patients 35 of whom had LNM. In all, measurements were done in 214 different samples of primary tumors and 211 lymph nodes. Sixty-one percent (27/44) of the primary tumors were found to have multiple DNA aneuploid stemlines when the data of the separate samples per tumor (mean 4.9) were compared. Only five of 44 (11%) primary tumors were DNA diploid; two of these had DNA aneuploid metastases. Statistical analysis of these results indicated that, on average, four samples are needed for reliable determination of the DNA ploidy status of primary tumors by flow cytometry. In the majority of the cases (26/35), distinct tumor DNA stemlines found in LNM were also present in the primary tumor, which suggests that the generation of DNA ploidy diversity may have taken place prior to metastasis. Multiploidy was not related to tumor size but, particularly for LNM, was significantly correlated with age (r = 0.40, P = 0.02). The results of this study support the view that breast cancer is an extremely heterogeneous disease and that underestimation of this factor might account for the disagreement in literature about the prognostic value of DNA ploidy determinations.
Beerman
H
H
Department of Pathology, Faculty of Medicine, University of Leiden, The Netherlands.
Smit
V T
VT
Kluin
P M
PM
Bonsing
B A
BA
Hermans
J
J
Cornelisse
C J
CJ
D002288:Adenocarcinoma, Mucinous / Q000737:chemistry / Q000235:genetics / Q000556:secondary; D000782:Aneuploidy; D001943:Breast Neoplasms / Q000737:chemistry* / Q000235:genetics / Q000473:pathology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000737:chemistry* / Q000235:genetics / Q000556:secondary; D004273:DNA, Neoplasm / Q000032:analysis*; D005434:Flow Cytometry; D008207:Lymphatic Metastasis; D014411:Neoplastic Stem Cells / Q000737:chemistry*; D011237:Predictive Value of Tests; D011379:Prognosis
D004273:DNA, Neoplasm